B Kaufman Selected Research

B Kaufman Research Topics

Disease

17	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2001
10	Neoplasms (Cancer) 12/2021 - 01/2000
3	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2008
2	Hemorrhage 01/2021 - 03/2011
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 01/2000
2	Disease Progression 11/2012 - 03/2011
1	Anemia 01/2022
1	Neutropenia 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 12/2021
1	Melanoma (Melanoma, Malignant) 12/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Acidosis 09/2018
1	Critical Illness (Critically Ill) 09/2018
1	Status Epilepticus (Complex Partial Status Epilepticus) 09/2018
1	Triple Negative Breast Neoplasms 11/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2014
1	Infections 05/2013
1	Adenocarcinoma 11/2012
1	Hypertension (High Blood Pressure) 03/2011
1	Venous Thromboembolism 03/2011
1	Proteinuria 03/2011
1	Inflammatory Breast Neoplasms 05/2010
1	Pain (Aches) 05/2010
1	Vomiting 03/2010
1	Diarrhea 03/2010
1	Nausea 03/2010
1	Atrophy 06/2007
1	Fibrosis (Cirrhosis) 06/2007
1	Wound Infection (Wound Infections) 05/2003
1	Cellulitis 05/2003
1	Pulmonary Infarction 12/2001
1	Pneumothorax 12/2001
1	Pulmonary Edema 12/2001

Drug/Important Bio-Agent (IBA)

5	AnthracyclinesIBA 01/2021 - 03/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 11/2012
4	taxaneIBA 01/2021 - 03/2010
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2016
3	Hormones (Hormone)IBA 01/2021 - 01/2010
3	Trastuzumab (Herceptin)FDA Link 01/2021 - 03/2010
3	human ERBB2 proteinIBA 01/2021 - 06/2010
3	Epidermal Growth Factor (EGF)IBA 01/2021 - 11/2008
3	Bevacizumab (Avastin)FDA Link 11/2014 - 03/2011
3	Capecitabine (Xeloda)FDA Link 11/2014 - 03/2010
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2018
2	veliparibIBA 01/2022 - 01/2018
2	Fulvestrant (Faslodex)FDA Link 01/2021 - 06/2010
2	N,N'-bis(4-azidobenzoyl)cystineIBA 10/2014 - 10/2014
2	Lapatinib (GW572016)FDA Link 05/2010 - 03/2010
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 12/2021
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	PlatinumIBA 01/2021
1	AlpelisibIBA 01/2021
1	Ketamine FDA LinkGeneric 09/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	olaparibIBA 01/2016
1	Biological ProductsIBA 09/2014
1	Peptides (Polypeptides)IBA 05/2013
1	Taxoids (Taxanes)IBA 05/2010
1	Pharmaceutical PreparationsIBA 03/2010
1	Proteins (Proteins, Gene)FDA Link 01/2010
1	CCAAT-Enhancer-Binding Protein-betaIBA 11/2008
1	Growth InhibitorsIBA 11/2008
1	Transcription Factors (Transcription Factor)IBA 11/2008
1	Insulin (Novolin)FDA Link 11/2008
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2003
1	5' Untranslated Regions (5' UTR)IBA 03/2001

Therapy/Procedure

6	Therapeutics 01/2022 - 05/2003
3	Drug Therapy (Chemotherapy) 01/2016 - 06/2007
1	Neoadjuvant Therapy 01/2021
1	Mastectomy (Mammectomy) 01/2019
1	Segmental Mastectomy (Lumpectomy) 05/2003
1	Central Venous Catheters 12/2001
1	Catheters 12/2001
1	Palliative Care (Palliative Therapy) 11/2000
1	Chemoprevention 01/2000